Lupin Pharmaceuticals Inc. has recalled 17,238 bottles of Gatifloxacin Ophthalmic Solution 0.5% because some bottles were distributed without any labeling. This prescription eye medication is used to treat bacterial infections in the eye and was sold in 2.5 mL sterile bottles nationwide across the United States and Puerto Rico. The recall specifically affects product lot H805157 with an expiration date of May 2020. Consumers should immediately check their medication to ensure the bottle is properly labeled to prevent misuse.
A missing label prevents patients from identifying the drug, understanding dosage instructions, or knowing the expiration date, which could lead to using the wrong medication or an ineffective treatment. Using an unidentified medication for an eye infection poses a significant risk of delayed recovery or potential adverse reactions if the product is confused with other eye drops.
Healthcare consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.